In this project, I analyzed data the data sourced from Pymaceuticals Inc., a burgeoning pharmaceutical company based out of San Diego. Pymaceuticals specialize in anti-cancer pharmaceuticals. In its most recent efforts, it began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer. The data gathered from 249 mice with SCC tumor growth were treated through a variety of drug regimens, and compares the performance of Pymaceuticals' drug of interest, Capomulin, versus the other treatment regimens and visualized the result.